Press release
Digital transformation to be the key to growth of the Uveitis Treatment Market
Global revenues of uveitis treatment market reached ~ 567 million in 2018, unveils the new research study by Persistence Market Research (PMR). According to the report, the uveitis treatment market is estimated to grow by ~6% CAGR in 2029, primarily attributed to rising R&D activities in the field of ophthalmology, increasing number of clinical trials for eye inflammation disorders treatment, increase in the investment in molecular biology, growing cases of infectious diseases, and increase in prevalence of uveitis.
The corticosteroids market is increasing a great deal of footing in the treatment landscape, as it has been the primary choice of medication for uveitis treatment by ophthalmologists. As corticosteroids are inexpensive, potent, and act fast, it has been used as a first line of therapy for patients with non-infectious ocular inflammatory diseases. Corticosteroids may be administered either topically, systemically or periocular injections. The antibiotics treatment type segment is expected to be the fastest growing segment in the uveitis treatment market during the forecast period, owing to rise in infectious ocular disorders globally.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/4430
Monoclonal antibodies in uveitis treatment is also expected to emerge as the most preferred treatment type for patients globally, during the forecast period. According to the report, in 2018 corticosteroids, monoclonal antibodies, and antibiotics constitute more than 50% of the total market revenue in the uveitis treatment market. Anterior uveitis is the most common form of uveitis constituting 75% of all cases of uveitis with annual incidence, 12 per 100,000. It is a prominent segment among the uveitis treatment markets diseases type which represents ~57% share of total market.
Company Profiles:
Allergan, Inc.
Novartis AG
Bausch Health Inc.
AbbVie Inc.
Eyegate Pharmaceuticals, Inc.
Alimera Science Inc.
EyePoint Pharmaceuticals
Santen Pharmaceuticals
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/4430
Infectious etiologies represent between 15–20% of all instances of uveitis in certain part of the United States, and likely represents a substantially more critical extent of uveitis around the world. Infectious uveitis holds a strong market share ~87% of the total uveitis treatment market due to growing cases associated with certain form of bacterial, viral, fungal, helminthic, and parasitic uveitis.
Emerging Therapies for Uveitis Treatment to Create Opportunities for Key Market Players
According to the PMR report, most ophthalmologists depend heavily on corticosteroids in uveitis treatment. But repeated use of corticosteroids in long term result in eye related complications.
Adjuvant treatment comprising cycloplegics, newer non–steroidal anti-inflammatory agents, and anti-vascular endothelial growth factor (anti-VEGF) therapy are used in uveitis treatment. In case of anterior uveitis, periocular corticoids, and unilateral intermediate, treatment is effective when rapidly administered along with anti-inflammatory drug at high concentration. Adjuvant immunosuppressors have often been utilized nowadays, which indicated better outcomes in the past.
Ongoing advances in local corticosteroids delivery and outside of the conventional injectable course have opened new opportunities for manufacturers for uveitis treatment and as an option for patients who experienced unilateral diseases, or the ones having an aversion to systemic medications. The new and running primary trend in the uveitis treatment market is the use of local steroid implants, that are proving out to be significantly accepted for drug delivery in case of noninfectious posterior uveitis.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/4430
Investments in Asia Pacific Representing Scope for the Uveitis Treatment Market Growth
According to the PMR report, North America shares the largest market share, while Asia Pacific is one of the fastest growing uveitis treatment market. The uveitis treatment market is seeing huge development, because of increasing pervasiveness of uveitis and related eye disorders. The worldwide uveitis treatment market as of now has numerous technologically manufactured products in the clinical trials pipeline, which are relied upon to improve efficiency and safety profiles in the clinical preliminary phase of development.
Moreover, increasing healthcare spending and developing awareness among doctors and patients in developing Asia Pacific nations are relied upon to bring about real opportunities for key players in the worldwide the uveitis treatment market. A research study by Persistence Market Research (PMR) reveals the Asia Pacific market for uveitis treatment market is relied upon to develop by CAGR ~6% and shares ~23% of market share and opens new doors for key players to grow their revenue by penetrating in this region.
Access Related Reports-
Triple Negative Breast Cancer Treatment Market: https://www.persistencemarketresearch.com/market-research/triple-negative-breast-cancer-treatment-market.asp
Renal Anemia Treatment Market: https://www.persistencemarketresearch.com/market-research/renal-anemia-treatment-market.asp
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com
About Us:
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunche
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Digital transformation to be the key to growth of the Uveitis Treatment Market here
News-ID: 2548007 • Views: …
More Releases from Persistence Market Research
Europe Automotive Heat Exchanger Market to Reach US$ 8.9 Billion by 2031, Exhibi …
The Europe automotive heat exchanger market has been witnessing steady growth, driven by the rapid evolution of vehicle technologies, stricter emission norms, and the widespread adoption of electric and hybrid vehicles. According to Persistence Market Research, the market is valued at US$ 6.4 billion in 2024 and is projected to reach US$ 8.9 billion by 2031, expanding at a CAGR of 4.9% during the forecast period from 2024 to 2031.…
Digital Crosspoint Switches Market Anticipated to Hit USD 52.5 Billion by 2032
Overview of the Digital Crosspoint Switches Market
The global digital crosspoint switches market is expected to be valued at US$ 28.9 billion in 2025, with projections to reach US$ 52.5 billion by 2032, growing at a robust CAGR of 8.9% during the forecast period. This growth is fueled by the surging need for high-speed data transmission, the expansion of next-generation telecommunications networks, and the increasing deployment of data centers worldwide. As…
Multiformat Transcoders Market Estimated to Grow at 8.6% CAGR by 2032
Overview of the Multiformat Transcoders Market
The global multiformat transcoders market is poised for remarkable expansion, with an estimated valuation of US$ 1.3 billion in 2025, projected to reach US$ 2.3 billion by 2032. This growth trajectory represents a robust CAGR of 8.6% during the forecast period (2025-2032). The market's expansion is driven by the surging demand for high-quality video streaming, advancements in cloud-based transcoding technologies, and the rising consumption of…
Automotive Bearing and Clutch Component Aftermarket Set for 4.5% CAGR Growth, Su …
The global automotive bearing and clutch component aftermarket is poised for steady expansion over the forecast period. According to the latest findings from Persistence Market Research, the market is projected to grow from an estimated US$ 5.3 billion in 2024 to approximately US$ 7.2 billion by 2031, reflecting a compound annual growth rate (CAGR) of 4.5%. This market covers the replacement of bearings, clutch kits, and related clutch components that…
More Releases for Uveitis
Uveitis Market : An Overview Report
Introduction:
Uveitis is an inflammatory condition affecting the uvea, the middle layer of the eye. It can lead to vision impairment or even blindness if left untreated. Uveitis is categorized into different types, including anterior, intermediate, posterior, and panuveitis, depending on the part of the eye affected. The condition can be caused by infections, autoimmune diseases, or trauma. With increasing cases of autoimmune disorders and infectious diseases, the prevalence of uveitis…
Uveitis Treatment Market Size, Share | Trend 2030
Exclusive Report by Ameco Research: Uveitis Treatment Market Size Projected to Reach USD 2 Billion by 2030, Growing at 6% CAGR
Ameco Research is proud to announce the launch of its latest market research report, Uveitis Treatment Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research…
Uveitis - Drug Pipeline Landscape, 2022
New York, Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of…
Uveitis - Drug Pipeline Landscape, 2022
Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of uveitis based…
Japan Industry Statistics of Uveitis Treatment
Global Uveitis Treatment Market: Overview
Uveitis, an autoimmune eye disease, is considered rare for just around 38 in 100,000 people are afflicted by it. Because of this, it is often overlooked. Patients afflicted by uveitis are often referred to an expert after much delay on account of less awareness about the eye malady. This delays timely diagnosis and results in irreversible damage to various ocular structures.
Read Report Overview: https://www.transparencymarketresearch.com/uveitis-treatment-market.html
As per Cochrane,…
Uveitis Treatment Market Analysis of Top industry Scenario
Global Uveitis Treatment Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables).
According to a new report published by Allied Market Research, titled, "Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy &…
